Patents by Inventor George D. Hartman

George D. Hartman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170114018
    Abstract: This disclosure provides crystalline forms of a hepatitis B antiviral agent, and methods of making and using these forms.
    Type: Application
    Filed: September 29, 2016
    Publication date: April 27, 2017
    Inventor: George D. Hartman
  • Patent number: 9579313
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: November 3, 2015
    Date of Patent: February 28, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Patent number: 9550779
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: January 24, 2017
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20170015629
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: September 27, 2016
    Publication date: January 19, 2017
    Inventors: George D. Hartman, Scott Kuduk
  • Patent number: 9527845
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: December 27, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Patent number: 9518057
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: December 13, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Patent number: 9505722
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: April 23, 2015
    Date of Patent: November 29, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20160272599
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: March 18, 2016
    Publication date: September 22, 2016
    Inventors: George D. Hartman, Scott Kuduk
  • Patent number: 9400280
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: March 26, 2015
    Date of Patent: July 26, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventor: George D. Hartman
  • Publication number: 20160185778
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 30, 2015
    Publication date: June 30, 2016
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20160185779
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 30, 2015
    Publication date: June 30, 2016
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20160185777
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: December 30, 2015
    Publication date: June 30, 2016
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20160158214
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Application
    Filed: November 3, 2015
    Publication date: June 9, 2016
    Inventor: George D. Hartman
  • Patent number: 9339510
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: September 17, 2015
    Date of Patent: May 17, 2016
    Assignee: NOVIRA THERAPEUTICS, INC.
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20160000812
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: September 17, 2015
    Publication date: January 7, 2016
    Inventors: George D. Hartman, Scott Kuduk
  • Patent number: 9205079
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in man.
    Type: Grant
    Filed: March 9, 2015
    Date of Patent: December 8, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventor: George D. Hartman
  • Patent number: 9181288
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: November 10, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20150315159
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: July 16, 2015
    Publication date: November 5, 2015
    Inventor: George D. Hartman
  • Patent number: 9169212
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Grant
    Filed: October 10, 2014
    Date of Patent: October 27, 2015
    Assignee: Novira Therapeutics, Inc.
    Inventors: George D. Hartman, Scott Kuduk
  • Publication number: 20150274652
    Abstract: Provided herein are compounds useful for the treatment of HBV infection in a subject in need thereof, pharmaceutical compositions thereof, and methods of inhibiting, suppressing, or preventing HBV infection in the subject.
    Type: Application
    Filed: March 26, 2015
    Publication date: October 1, 2015
    Inventor: George D. Hartman